We provide here the most relevant findings associated with the aberrant expression of Cx30, Cx36, and Cx43 in AD, PD, and HD, which could encourage to study the regulation in the expression of Cxs during the onset and progression of these disorders. This evidence concerns the gene GJD2 and Parkinson disease.